The metabolic bioactivation of caffeic acid phenethyl ester (CAPE) mediated by tyrosinase selectively inhibits glutathione S-transferase

Chemico-Biological Interactions

Volumn 192, Issue 3, 2011, Pages 243-256

  Kudugunti, Shashi K ^a   Thorsheim, Helen ^a   Yousef, Mohammad S ^b,c   Guan, Lan ^b   Moridani, Majid Y ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Caffeic acid phenethyl ester; Glutathione; GST; Melanoma; MRP; Quinone

Indexed keywords

CAFFEIC ACID; CAFFEIC ACID PHENETHYL ESTER; GLUTATHIONE TRANSFERASE; MONOPHENOL MONOOXYGENASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG ACTIVATION; DRUG BINDING SITE; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; LIQUID CHROMATOGRAPHY; MELANOMA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR DOCKING; PROTEIN FUNCTION; TANDEM MASS SPECTROMETRY;

CAFFEIC ACIDS; CELL LINE, TUMOR; ENZYME INHIBITORS; GLUTATHIONE TRANSFERASE; HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; PHENYLETHYL ALCOHOL;

EID: 79957667508     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2011.03.015     Document Type: Article

References (63)

1. S.K. Kudugunti, N.M. Vad, E. Ekogbo, M.Y. Moridani, Efficacy of caffeic acid phenethyl ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL/6 mice, Invest. New Drugs 29 (1) (2009) 52-62.
2. D. Schadendorf, A. Makki, C. Stahr, A. van Dyck, R. Wanner, G.L. Scheffer, M.J. Flens, R. Scheper, B.M. Henz, Membrane transport proteins associated with drug resistance expressed in human melanoma, Am. J. Pathol. 147 (6) (1995) 1545-1552.
3. B.D. Banerjee, V. Seth, A. Bhattacharya, S.T. Pasha, A.K. Chakraborty, Biochemical effects of some pesticides on lipid peroxidation and free-radical scavengers, Toxicol. Lett. 107 (1-3) (1999) 33-47.
4. A. Sau, F. Pellizzari Tregno, F. Valentino, G. Federici, A.M. Caccuri, Glutathione transferases and development of new principles to overcome drug resistance, Arch. Biochem. Biophys. 500 (2) (2010) 116-122.
5. S. Mena, A. Ortega, J.M. Estrela, Oxidative stress in environmental-induced carcinogenesis, Mutat. Res. 674 (1-2) (2009) 36-44.
6. K. Johansson, K. Ahlen, R. Rinaldi, K. Sahlander, A. Siritantikorn, R. Morgenstern, Microsomal glutathione transferase 1 in anticancer drug resistance, Carcinogenesis 28 (2) (2007) 465-470. (Pubitemid 46321864)
7. R. Pastila, D. Leszczynski, Ultraviolet-A radiation induces changes in cyclin G gene expression in mouse melanoma B16-F1 cells, Cancer Cell Int. 7 (2007) 7.
8. C.S. Morrow, P.K. Smitherman, S.K. Diah, E. Schneider, A.J. Townsend, Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells, J. Biol. Chem. 273 (32) (1998) 20114-20120.
9. P. Depeille, P. Cuq, I. Passagne, A. Evrard, L. Vian, Combined effects of GSTP1 and MRP1 in melanoma drug resistance, Br. J. Cancer 93 (2) (2005) 216-223. (Pubitemid 41133208)
10. S.P. Cole, G. Bhardwaj, J.H. Gerlach, J.E. Mackie, C.E. Grant, K.C. Almquist, A.J. Stewart, E.U. Kurz, A.M. Duncan, R.G. Deeley, Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line, Science 258 (5088) (1992) 1650-1654. (Pubitemid 23012438)
11. P. Borst, R. Evers, M. Kool, J. Wijnholds, The multidrug resistance protein family, Biochim. Biophys. Acta 1461 (2) (1999) 347-357.
12. M. O'Brien, G.D. Kruh, K.D. Tew, The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance, J. Pharmacol. Exp. Ther. 294 (2) (2000) 480-487. (Pubitemid 30490819)
13. A. Moral, J. Palou, A. Lafuente, R. Molina, J. Piulachs, T. Castel, M. Trias, Immunohistochemical study of alpha, mu and pi class glutathione S transferase expression in malignant melanoma. MMM Group. Multidisciplinary Malignant Melanoma Group, Br. J. Dermatol. 136 (3) (1997) 345-350.
14. S.K. Kudugunti, N.M. Vad, A.J. Whiteside, B.U. Naik, M.A. Yusuf, K.S. Srivenugopal, M.Y. Moridani, Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines, Chem. Biol. Interact. 188 (1) (2010) 1-14.
15. Y.M. Chen, W. Chavin, Tyrosinase activity in a highly pigmented human melanoma and in Negro skin, Proc. Soc. Exp. Biol. Med. 145 (2) (1974) 695-698.
16. L. Guarini, Z.Z. Su, S. Zucker, J. Lin, D. Grunberger, P.B. Fisher, Growth inhibition and modulation of antigenic phenotype in human melanoma and glioblastoma multiforme cells by caffeic acid phenethyl ester (CAPE), Cell Mol. Biol. 38 (5) (1992) 513-527.
17. 2+-signaling involved in adenosine triphosphate export via Gq protein-coupled NK2-receptor stimulation with neurokinin A, J. Pharmacol. Sci. 114 (1) (2010) 92-98.
18. E. Vamos, K. Voros, D. Zadori, L. Vecsei, P. Klivenyi, Neuroprotective effects of probenecid in a transgenic animal model of Huntington's disease, J. Neural. Transm. 116 (9) (2009) 1079-1086.
19. K. Asaoka, Affinity purification and characterization of glutathione S-transferases from bovine liver, J. Biochem. 95 (3) (1984) 685-696.
20. C.Y. Lee, Multiple forms of mouse glutathione S-transferases, Biochem. Soc. Trans. 12 (1) (1984) 30-33.
21. M.Y. Moridani, H. Scobie, P.J. O'Brien, Metabolism of caffeic acid by isolated rat hepatocytes and subcellular fractions, Toxicol. Lett. 133 (2-3) (2002) 141-151.
22. D. Gergel, A.I. Cederbaum, Interaction of nitric oxide with 2-thio-5-nitrobenzoic acid: implications for the determination of free sulfhydryl groups by Ellman's reagent, Arch. Biochem. Biophys. 347 (2) (1997) 282-288. (Pubitemid 27492801)
23. M.Y. Moridani, M. Moore, R.A. Bartsch, Y. Yang, S. Heibati-Sadati, Structural toxicity relationship of 4-alkoxyphenols' cytotoxicity towards murine B16-F0 melanoma cell line, J. Pharm. Pharm. Sci. 8 (2) (2005) 348-360. (Pubitemid 41519149)
24. G. Tuna, G.K. Erkmen, O. Dalmizrak, A. Dogan, I.H. Ogus, N. Ozer, Inhibition characteristics of hypericin on rat small intestine glutathione-S-transferases, Chem. Biol. Interact. 188 (1) (2010) 59-65.
25. W.H. Habig, M.J. Pabst, W.B. Jakoby, Glutathione S-transferases. The first enzymatic step in mercapturic acid formation, J. Biol. Chem. 249 (22) (1974) 7130-7139.
26. S. Oetari, M. Sudibyo, J.N. Commandeur, R. Samhoedi, N.P. Vermeulen, Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver, Biochem. Pharmacol. 51 (1) (1996) 39-45.
27. Y.R. Pokharel, E.H. Han, J.Y. Kim, S.J. Oh, S.K. Kim, E.R. Woo, H.G. Jeong, K.W. Kang, Potent protective effect of isoimperatorin against aflatoxin B1-inducible cytotoxicity in H4IIE cells: bifunctional effects on glutathione S-transferase and CYP1A, Carcinogenesis 27 (12) (2006) 2483-2490. (Pubitemid 44884107)
28. N.M. Vad, G. Yount, D. Moore, J. Weidanz, M.Y. Moridani, Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines, J. Pharm. Sci. 98 (4) (2009) 1409-1425.
29. N.M. Vad, S.K. Kudugunti, D. Graber, N. Bailey, K. Srivenugopal, M.Y. Moridani, Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice, Int. J. Oncol. 35 (1) (2009) 193-204.
30. K.D. Tew, S. Dutta, M. Schultz, Inhibitors of glutathione S-transferases as therapeutic agents, Adv. Drug Deliv. Rev. 26 (2-3) (1997) 91-104. (Pubitemid 27289527)
31. M.L. Iersel, J.P. Ploemen, I. Struik, C. van Amersfoort, A.E. Keyzer, J.G. Schefferlie, P.J. van Bladeren, Inhibition of glutathione S-transferase activity in human melanoma cells by alpha,beta-unsaturated carbonyl derivatives. Effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal, Chem. Biol. Interact. 102 (2) (1996) 117-132.
32. X.J. Shang, G. Yao, J.P. Ge, Y. Sun, W.H. Teng, Y.F. Huang, Procyanidin induces apoptosis and necrosis of prostate cancer cell line PC-3 in a mitochondrion-dependent manner, J. Androl. 30 (2) (2009) 122-126.
33. A. Wong, L. Cavelier, H.E. Collins-Schramm, M.F. Seldin, M. McGrogan, M.L. Savontaus, G.A. Cortopassi, Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells, Hum. Mol. Genet. 11 (4) (2002) 431-438. (Pubitemid 34213616)
34. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, A.J. Olson, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function, J. Comput. Chem. 19 (1998) 1639-1662.
35. M.F.S. Sanner, The Scripps Python: a programming language for software integration and development, J. Mol. Graphics Mod. 17 (1999) 57-61.
36. I. Quesada-Soriano, L.J. Parker, A. Primavera, J. Wielens, J.K. Holien, J.M. Casas-Solvas, A. Vargas-Berenguel, A.M. Aguilera, M. Nuccetelli, A.P. Mazzetti, M.L. Bello, M.W. Parker, L. Garcia-Fuentes, Diuretic drug binding to human glutathione transferase P1-1: potential role of Cys-101 revealed in the double mutant C47S/Y108V, J. Mol. Recognit. (2010).
37. A.J. Oakley, M. Lo Bello, A.P. Mazzetti, G. Federici, M.W. Parker, The glutathione conjugate of ethacrynic acid can bind to human pi class glutathione transferase P1-1 in two different modes, FEBS Lett. 419 (1) (1997) 32-36. (Pubitemid 28011211)
38. S. Awasthi, S.K. Srivastava, F. Ahmad, H. Ahmad, G.A. Ansari, Interactions of glutathione S-transferase-pi with ethacrynic acid and its glutathione conjugate, Biochim. Biophys. Acta 1164 (2) (1993) 173-178.
39. M.Y. Moridani, Biochemical basis of 4-hydroxyanisole induced cell toxicity towards B16-F0 melanoma cells, Cancer Lett. 243 (2) (2006) 235-245. (Pubitemid 44508705)
40. J. Choi, S.J. Bae, Y.M. Ha, J.K. No, E.K. Lee, J.S. Lee, S. Song, H. Lee, H. Suh, B.P. Yu, H.Y. Chung, A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol, Bioorg. Med. Chem. Lett. 20 (16) (2010) 4882-4884.
41. J.H. Ploemen, B. van Ommen, A. de Haan, J.G. Schefferlie, P.J. van Bladeren, In vitro and in vivo reversible and irreversible inhibition of rat glutathione S-transferase isoenzymes by caffeic acid and its 2-S-glutathionyl conjugate, Food Chem. Toxicol. 31 (7) (1993) 475-482.
42. N. Celli, L.K. Dragani, S. Murzilli, T. Pagliani, A. Poggi, In vitro and in vivo stability of caffeic acid phenethyl ester, a bioactive compound of propolis, J. Agric. Food Chem. 55 (9) (2007) 3398-3407.
43. S.C. McNeely, A.C. Belshoff, B.F. Taylor, T.W. Fan, M.J. McCabe Jr., A.R. Pinhas, J.C. States, Sensitivity to sodium arsenite in human melanoma cells depends upon susceptibility to arsenite-induced mitotic arrest, Toxicol. Appl. Pharmacol. 229 (2) (2008) 252-261.
44. D.M. Townsend, Y. Manevich, L. He, S. Hutchens, C.J. Pazoles, K.D. Tew, Novel role for glutathione S-transferase pi. Regulator of protein S-glutathionylation following oxidative and nitrosative stress, J. Biol. Chem. 284 (1) (2009) 436-445.
45. Y.C. Awasthi, R. Sharma, S. Yadav, S. Dwivedi, A. Sharma, S. Awasthi, The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistance, Curr. Drug Metab. 8 (4) (2007) 315-323.
46. H. Helmbach, E. Rossmann, M.A. Kern, D. Schadendorf, Drug-resistance in human melanoma, Int. J. Cancer 93 (5) (2001) 617-622. (Pubitemid 32695107)
47. L. Serrone, P. Hersey, The chemoresistance of human malignant melanoma: an update, Melanoma Res. 9 (1) (1999) 51-58. (Pubitemid 29169989)
48. H.F. Liao, Y.Y. Chen, J.J. Liu, M.L. Hsu, H.J. Shieh, H.J. Liao, C.J. Shieh, M.S. Shiao, Y.J. Chen, Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis, J. Agric. Food Chem. 51 (27) (2003) 7907-7912.
49. T.W. Chung, S.K. Moon, Y.C. Chang, J.H. Ko, Y.C. Lee, G. Cho, S.H. Kim, J.G. Kim, C.H. Kim, Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism, FASEB J. 18 (14) (2004) 1670-1681. (Pubitemid 39463706)
50. D. Grunberger, R. Banerjee, K. Eisinger, E.M. Oltz, L. Efros, M. Caldwell, V. Estevez, K. Nakanishi, Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis, Experientia 44 (3) (1988) 230-232. (Pubitemid 18066629)
51. M.Y. Moridani, H. Scobie, A. Jamshidzadeh, P. Salehi, P.J. O'Brien, Caffeic acid, chlorogenic acid, and dihydrocaffeic acid metabolism: glutathione conjugate formation. Metabolic activation of 4-hydroxyanisole by isolated rat hepatocytes, Drug Metab. Dispos. 29 (11) (2001) 1432-1439.
52. J. Choi, S.J. Bae, M. Ha, J.K. No, E.K. Lee, J.S. Lee, S. Song, H. Lee, H. Suh, B.P. Yu, H.Y. Chung, A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol, Bioorg. Med. Chem. Lett. 20 (16) (2010) 4882-4884.
53. T. Asakura, A. Sasagawa, H. Takeuchi, S. Shibata, H. Marushima, S. Mamori, K. Ohkawa, Conformational change in the active center region of GST P1-1, due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis, Apoptosis 12 (7) (2007) 1269-1280.
54. M.H. Lyttle, M.D. Hocker, H.C. Hui, C.G. Caldwell, D.T. Aaron, A. Engqvist-Goldstein, J.E. Flatgaard, K.E. Bauer, Isozyme-specific glutathione-S-transferase inhibitors: design and synthesis, J. Med. Chem. 37 (1) (1994) 189-194.
55. T. Thangasamy, S. Sittadjody, S. Lanza-Jacoby, P.R. Wachsberger, K.H. Limesand, R. Burd, Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase, Nutr. Cancer 59 (2) (2007) 258-268. (Pubitemid 350230743)
56. J.J. van Zanden, O. Ben Hamman, M.L. van Iersel, S. Boeren, N.H. Cnubben, M. Lo Bello, J. Vervoort, P.J. van Bladeren, I.M. Rietjens, Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin, Chem. Biol. Interact. 145 (2) (2003) 139-148. (Pubitemid 36398427)
57. M. Kurata, M. Suzuki, K. Takeda, Effects of phenol compounds, glutathione analogues and a diuretic drug on glutathione S-transferase, glutathione reductase and glutathione peroxidase from canine erythrocytes, Comp. Biochem. Physiol. B 103 (4) (1992) 863-867.
58. F.J. Sanchez-Gomez, B. Diez-Dacal, M.A. Pajares, O. Llorca, D. Perez-Sala, Cyclopentenone prostaglandins with dienone structure promote cross-linking of the chemoresistance-inducing enzyme glutathione S-transferase P1-1, Mol. Pharmacol. 78 (4) (2010) 723-733.
59. S. Aizawa, K. Ookawa, T. Kudo, J. Asano, M. Hayakari, S. Tsuchida, Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine, Cancer Sci. 94 (10) (2003) 886-893. (Pubitemid 37406971)
60. A. Harbottle, A.K. Daly, K. Atherton, F.C. Campbell, Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance, Int. J. Cancer 92 (6) (2001) 777-783. (Pubitemid 32467364)
61. P. Horak, E. Sild, U. Soomets, T. Sepp, K. Kilk, Oxidative stress and information content of black and yellow plumage coloration: an experiment with greenfinches, J. Exp. Biol. 213 (Pt 13) (2010) 2225-2233.
62. P. Depeille, P. Cuq, S. Mary, I. Passagne, A. Evrard, D. Cupissol, L. Vian, Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects, Mol. Pharmacol. 65 (4) (2004) 897-905.
63. A. Ortega, J. Carretero, E. Obrador, J.M. Estrela, Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high GSH and Bcl-2 levels, Nitric Oxide 19 (2) (2008) 107-114.